For years, specimens from former mental health patients were meticulously labeled in scientific language at the Indiana Medical History Museum. Now, for the first time, visitors can see the human stories behind those specimens, following an intensive, four-year project.
Researchers at Purdue have won a $2.5 million, five-year federal grant to screen existing drugs to see if they can help attack antibiotic-resistant infections.
A research team says it has found a way to extend the life of implantable stimulation devices that help patients recover from strokes, Alzheimer’s and other neurological diseases.
The project is the largest in a decade for the hospital in northern Morgan County, about 18 miles from Franciscan Health’s flagship hospital on the south side of Indianapolis.
With just a few exceptions, Indianapolis’ life sciences and health care community is turning out in force for the festival, with sponsorships, exhibit booths and parade units.
IU Health has been pushing in recent months to build its in-house team of neurosurgeons and will end its relationship in December with Goodman Campbell, which has provided a big part of neurosurgery services at hospitals and the medical school for the past nine years.
The Indianapolis-based drugmaker has updated the label on Verzenio with a new warning after Japanese health officials said the drug is suspected of adversely affecting patients’ lungs.
One of the project’s partners, Post Acute Medical LLC of Pennsylvania, has been shutting down hospitals in Texas and Wisconsin in recent months.
The Indianapolis-based company also announced a deal to cover nearly 4,000 government workers and dependents in Hamilton County, Ohio.